论文信息 - NCCN Guidelines Insights: Breast Cancer, Version 3.2018. - 字舞流文

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.

Amy M. Sitapati | Amy Sitapati | Chau Dang | Jame Abraham | Hatem Soliman | Rashmi Kumar | Matthew P Goetz | Ingrid A Mayer | P Kelly Marcom | W. Gradishar | R. Aft | Rashmi Kumar | H. Rugo | H. Burstein | K. Allison | M. Goetz | Dorothy Shead | L. Pierce | P. Marcom | S. Giordano | B. Anderson | M. Smith | J. Abraham | S. Isakoff | R. O'Regan | I. Mayer | L. Goldstein | A. Elias | W. Farrar | J. Mortimer | K. Smith | E. Reed | J. Ward | M. Moran | H. Soliman | Hope S Rugo | Benjamin O Anderson | Steven J Isakoff | Mary Lou Smith | Sarah L Blair | Lori J Goldstein | John H Ward | William J Gradishar | Joanne Mortimer | Harold J Burstein | Sharon H Giordano | Meena S Moran | M. Telli | C. Dang | S. Blair | Kimberly H Allison | Dorothy A Shead | J. Lyons | Sameer A. Patel | Sameer A Patel | William B Farrar | Lori J Pierce | Elizabeth C Reed | Melinda L Telli | Anthony D Elias | Janice Lyons | Ruth M O'Regan | Karen Lisa Smith | Rebecca Aft | Jessica S Young | Jessica S. Young